NORGES BANK - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 176 filers reported holding PDL BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORGES BANK ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2017$3,763,000
-12.5%
1,373,360
+8.3%
0.00%
-50.0%
Q3 2017$4,301,000
+7.0%
1,268,659
-22.0%
0.00%0.0%
Q2 2017$4,019,000
-8.8%
1,627,075
-16.2%
0.00%0.0%
Q1 2017$4,409,000
-13.0%
1,942,075
-18.8%
0.00%0.0%
Q4 2016$5,068,000
-25.5%
2,390,505
+12.4%
0.00%
-33.3%
Q3 2016$6,802,000
+18.8%
2,125,988
+16.6%
0.00%0.0%
Q2 2016$5,726,000
+58.0%
1,823,488
+67.6%
0.00%
+50.0%
Q1 2016$3,623,000
+7.6%
1,088,046
+14.4%
0.00%0.0%
Q4 2015$3,367,000
-53.7%
951,046
-34.2%
0.00%
-50.0%
Q3 2015$7,269,000
-12.7%
1,445,120
+11.5%
0.00%0.0%
Q2 2015$8,331,000
-8.6%
1,295,7170.0%0.00%0.0%
Q1 2015$9,115,000
-16.2%
1,295,717
-8.2%
0.00%
-33.3%
Q4 2014$10,880,000
-15.0%
1,411,130
-17.7%
0.01%
-14.3%
Q3 2014$12,806,000
-61.4%
1,714,394
-50.0%
0.01%
-22.2%
Q2 2014$33,190,000
+273.5%
3,428,788
+220.6%
0.01%
+80.0%
Q1 2014$8,887,000
-1.5%
1,069,4360.0%0.01%0.0%
Q4 2013$9,026,000
+5.9%
1,069,4360.0%0.01%0.0%
Q3 2013$8,524,000
+59.2%
1,069,436
+54.2%
0.01%
+66.7%
Q2 2013$5,355,000
+5.6%
693,7000.0%0.00%0.0%
Q1 2013$5,071,000
-4.9%
693,7000.0%0.00%
-25.0%
Q3 2012$5,335,000
+13.2%
693,7000.0%0.00%0.0%
Q2 2012$4,711,000693,7000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2017
NameSharesValueWeighting ↓
SMH CAPITAL ADVISORS INC 81,713$176,0000.39%
BRANDES INVESTMENT PARTNERS, LP 5,465,156$11,805,0000.30%
Crestline Management, LP 875,000$1,890,0000.30%
West Family Investments, Inc. 539,450$1,165,0000.29%
WEBER ALAN W 200,000$432,000,0000.19%
Zebra Capital Management LLC 73,910$160,0000.18%
RBF Capital, LLC 569,323$1,230,0000.14%
Leap Investments LP 69,496$150,0000.08%
Connor, Clark & Lunn Investment Management Ltd. 4,387,038$9,476,0000.06%
CHICAGO EQUITY PARTNERS LLC 519,315$1,122,0000.05%
View complete list of PDL BIOPHARMA INC shareholders